TASP0415914 是一种有效且具有口服活性的 PI3Kγ 抑制剂，IC50 为 29 nM。TASP0415914 还显示出有效的 Akt 抑制活性，IC50 为 294 nM。TASP0415914 可用于炎症性疾病的研究。
货号:ajcx33532
CAS:1292300-75-4
分子式:C13H17N5O3S
分子量：323.37
溶解度:DMSO : 125 mg/mL (386.55 mM; Need ultrasonic)
纯度：98%
存储：Store at -20°C
库存：现货

Background:

TASP0415914 is a potent and orally active PI3Kγ inhibitor with an IC50 of 29 nM. TASP0415914 also shows potent Akt inhibitory activities with an IC50 of 294 nM. TASP0415914 can be used for inflammatory diseases research[1].

TASP0415914 (compound 8j) shows high metabolic stability in rat/human liver microsomes. TASP0415914 has no CYP inhibition up to 10 μM for CYP1A2, 2C9, 2C19, 2D6 and 3A4[1].

TASP0415914 (compound 8j; 10-100 mg/kg; orally administration; twice daily; for 14 days) treatment suppressed the progression of the disease in a dose-dependent manner in a mouse collagen-induced arthritis (CIA) model[1].

[1]. Yusuke Oka, et al. Discovery of N-{5-[3-(3-hydroxypiperidin-1-yl)-1,2,4-oxadiazol-5-yl]-4-methyl-1,3-thiazol-2-yl}acetamide (TASP0415914) as an orally potent phosphoinositide 3-kinase γ inhibitor for the treatment of inflammatory diseases. Bioorg Med Chem. 2013 Dec 15;21(24):7578-83.